Trulieve Cannabis CORP 8-K filings

Trulieve Cannabis Corp. has successfully completed its domestication from British Columbia, Canada, to Delaware, USA, effective August 11, 2026, with no change to its stock structure or shareholder rights.

Trulieve Cannabis Corp. announced its second quarter 2026 results, highlighting $271 million in revenue and a 60% gross margin, alongside its historic listing on the New York Stock Exchange.

Trulieve Cannabis Corp. announced the elimination of its Chief Accounting Officer position and the termination of Brett Walsh, appointing CFO Jan Reese as principal accounting officer.

Trulieve Cannabis Corp. announced the immediate departure of President Jason Pernell, effective June 11, 2026.

Trulieve Cannabis Corp. reports strong shareholder approval for director elections and auditor ratification at its recent annual meeting.

Trulieve Cannabis Corp. has authorized a share repurchase program allowing for the buyback of up to $50 million in subordinate voting shares over a 12-month period.

Trulieve Cannabis Corp. has deconsolidated its mixed-use cannabis business, Harvest Enterprises, LLC, to prepare for a potential New York Stock Exchange listing.

Trulieve Cannabis Corp. announced first quarter 2026 results, reporting $287 million in revenue, a 59% gross margin, and $2 million in net income, alongside $100 million in Adjusted EBITDA.

Trulieve Cannabis Corp. director Thad Beshears will not stand for reelection at the upcoming June 2026 annual meeting.

Trulieve Cannabis Corp. announced a leadership transition, appointing Brett Walsh as Chief Accounting Officer following the termination of Joy Malivuk.

Trulieve Cannabis Corp. announced its full year 2025 results, highlighting record cash flow and strategic debt repositioning despite a slight revenue dip.

Trulieve Cannabis Corp. has closed a private placement of an additional US$60 million in 10.5% senior secured notes due 2030, bringing the total outstanding to US$200 million.

Trulieve Cannabis Corp. has successfully closed a private placement of $140 million in 10.5% Senior Secured Notes due December 17, 2030, to fund capital expenditures and general corporate purposes.

Trulieve Cannabis Corp. announced commitments for a $100 million private placement of 10.5% Senior Secured Notes due 2030 to fund capital expenditures and general corporate purposes.

Trulieve Cannabis Corp. reports Q3 2025 results with $288 million revenue, robust cash flow, and strategic operational advancements despite a net loss.

Trulieve Cannabis Corp. announced the redemption of all its outstanding US$368 million 8% Senior Secured Notes due 2026, effective December 5, 2025.

Trulieve Cannabis Corp. announced the appointment of Matthew Foulston to its Board of Directors and Jan Reese as its new Chief Financial Officer, effective September 8, 2025.

Trulieve Cannabis Corp. announced its second quarter 2025 results, showing comparable revenue, increased net loss, and strong cash flow from operations.

Trulieve Cannabis Corp. shareholders approved an expanded equity incentive plan, the election of seven directors, and executive compensation at its annual meeting, despite significant opposition votes on key proposals.

Trulieve Cannabis Corp. announces its first quarter 2025 results, highlighting stable revenue, improved gross margins, and strategic focus areas for future growth.

Trulieve Cannabis Corp. announces the resignation of CFO Wes Getman and the appointment of Ryan Blust as interim CFO, effective March 6, 2025.

Trulieve announced its Q4 and full year 2024 results, reporting a 5% year-over-year revenue increase for both periods, strong gross margins, and record cash flow from operations.

Trulieve Cannabis Corp. announced a 3% year-over-year revenue increase to $284 million for Q3 2024, alongside a net loss of $60 million, while heavily investing in Florida's adult-use cannabis campaign.

Trulieve Cannabis Corp. reported a strong second quarter with $303 million in revenue, a 60% gross margin, and the launch of adult use sales in Ohio.

Trulieve Cannabis Corp. shareholders approved an amendment to the company's 2021 Omnibus Incentive Plan, increasing the share pool by 5.5 million subordinate voting shares.

Trulieve Cannabis Corp. announced a solid first quarter of 2024, marked by revenue growth, improved gross margins, and strong cash flow generation.

Giannella Alvarez will not seek reelection to Trulieve Cannabis Corp.'s board of directors at the upcoming annual meeting on June 12, 2024.

Trulieve Cannabis Corp. has dismissed Marcum LLP as its independent auditor and appointed WithumSmith+Brown, PC, citing material weaknesses in internal controls.

Trulieve Cannabis Corp. announced strong fourth quarter and full year 2023 results, highlighted by record cash flow from operations and improved gross margins.

Trulieve Cannabis Corp. has appointed Marie Zhang as Chief Operating Officer, effective January 29, 2024, and has also increased the base salaries of several key executives.